- Report
- June 2025
- 150 Pages
Global
From €5248EUR$5,950USD£4,525GBP
- Report
- May 2025
- 245 Pages
Global
From €5248EUR$5,950USD£4,525GBP
- Report
- May 2025
- 100 Pages
Global
From €5248EUR$5,950USD£4,525GBP
- Report
- May 2025
- 137 Pages
Global
From €5248EUR$5,950USD£4,525GBP
- Report
- May 2025
- 195 Pages
Global
From €5248EUR$5,950USD£4,525GBP
- Report
- May 2025
- 195 Pages
Global
From €5248EUR$5,950USD£4,525GBP
- Report
- November 2025
- 150 Pages
Global
From €5248EUR$5,950USD£4,525GBP
- Report
- February 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,415GBP
- Report
- February 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,415GBP
- Report
- February 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,415GBP
- Report
- January 2026
- 250 Pages
Global
From €3960EUR$4,490USD£3,415GBP
- Report
- May 2026
- 2285 Pages
Global
From €1140EUR$1,338USD£950GBP
- Report
- May 2026
- 83 Pages
Global
From €1140EUR$1,338USD£950GBP
- Report
- November 2025
- 188 Pages
Global
From €3127EUR$3,545USD£2,696GBP
€3474EUR$3,939USD£2,996GBP
- Report
- October 2025
- 140 Pages
Global
From €5248EUR$5,950USD£4,525GBP
- Report
- December 2025
- 200 Pages
Global
From €2637EUR$2,990USD£2,274GBP
- Report
- January 2026
- 193 Pages
Global
From €3127EUR$3,545USD£2,696GBP
€3474EUR$3,939USD£2,996GBP
- Report
- January 2026
- 187 Pages
Global
From €3127EUR$3,545USD£2,696GBP
€3474EUR$3,939USD£2,996GBP
- Report
- January 2026
- 198 Pages
Global
From €3127EUR$3,545USD£2,696GBP
€3474EUR$3,939USD£2,996GBP
- Report
- January 2026
- 194 Pages
Global
From €3127EUR$3,545USD£2,696GBP
€3474EUR$3,939USD£2,996GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more